Continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: Do the benefits outweigh the risks? | Zendy

Gillian H Toth | Zendy

Open Access

Continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes: Do the benefits outweigh the risks?

Author(s) -

Gillian H Toth

Publication year - 2005

Publication title -

paediatrics and child health

Language(s) - English

Resource type - Journals

eISSN - 1918-1485

pISSN - 1205-7088

DOI - 10.1093/pch/10.1.28

Subject(s) - medicine , insulin , type 1 diabetes , diabetic ketoacidosis , ketoacidosis , diabetes mellitus , intensive care medicine , insulin delivery , type 2 diabetes , pediatrics , insulin pump , endocrinology

Intensive management of diabetes is the gold standard in the treatment of children with type 1 diabetes. Novel insulin delivery techniques have been developed to improve the ability to administer multiple daily doses of insulin. Continuous subcutaneous insulin infusion (CSII) is a method of insulin delivery that is increasing in popularity. The present article reviews the risks and benefits of CSII in children. At this time, there is limited quality published evidence to make a definitive claim about the potential risks and benefits of CSII in children. The risk of diabetic ketoacidosis and individual family factors must be considered before initiation of treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research